| Literature DB >> 32937866 |
Tatjana Vilibic-Cavlek1,2, Snjezana Zidovec-Lepej3, Dragan Ledina4,5, Samira Knezevic6, Vladimir Savic7, Irena Tabain1, Ivo Ivic4,5, Irena Slavuljica6,8, Maja Bogdanic1, Ivana Grgic3, Lana Gorenec3, Vladimir Stevanovic9, Ljubo Barbic9.
Abstract
Toscana virus (TOSV) is an arthropod-borne virus, transmitted to humans by phlebotomine sandflies. Although the majority of infections are asymptomatic, neuroinvasive disease may occur. We report three cases of neuroinvasive TOSV infection detected in Croatia. Two patients aged 21 and 54 years presented with meningitis, while a 22-year old patient presented with meningoencephalitis and right-sided brachial plexitis. Cerebrospinal fluid (CSF), serum, and urine samples were collected and tested for neuroinvasive arboviruses: tick-borne encephalitis, West Nile, Usutu, TOSV, Tahyna, and Bhanja virus. In addition, CSF and serum samples were tested for the anti-viral cytokine response. High titers of TOSV IgM (1000-3200) and IgG (3200-10,000) antibodies in serum samples confirmed TOSV infection. Antibodies to other phleboviruses (sandfly fever Sicilian/Naples/Cyprus virus) were negative. CSF samples showed high concentrations of interleukin 6 (IL-6; range 162.32-2683.90 pg/mL), interferon gamma (IFN-γ; range 110.12-1568.07 pg/mL), and IL-10 (range 28.08-858.91 pg/mL), while significantly lower cytokine production was observed in serum. Two patients recovered fully. The patient with a brachial plexitis improved significantly at discharge. The presented cases highlight the need of increasing awareness of a TOSV as a possible cause of aseptic meningitis/meningoencephalitis during summer months. Association of TOSV and brachial plexitis with long-term sequelae detected in one patient indicates the possibility of more severe disease, even in young patients.Entities:
Keywords: Croatia; Toscana virus; clinical presentation; immunology; neuroinvasive disease; virology
Year: 2020 PMID: 32937866 PMCID: PMC7557803 DOI: 10.3390/tropicalmed5030144
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Epidemiological and Clinical Characteristics of Patients with Toscana Neuroinvasive Infection.
| Characteristic | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
| Age | 21 years | 22 years | 54 years |
| Gender | Male | Female | Male |
| Area of residence | Croatian littoral | Croatian mainland | Croatian littoral |
| Time of disease onset | Late August | Late August | Mid October |
| Clinical presentation | Meningitis | Meningoencephalitis | Meningitis |
| Clinical symptoms | Fever (up to 38 °C), headache, nausea, vomiting, photophobia, weakness | Fever (up to 38 °C), headache, nausea, vomiting, photophobia, dizziness, weakness, arthralgia, maculopapular rash, right-sided brachial plexitis | Severe headache, vomiting, weakness |
| Duration of symptoms | 5 days | 20 days | 5 days |
| Outcome | Recovered | Improved | Recovered |
Virology Results in Patients with Toscana Neuroinvasive Infection.
| Virus | CASE 1 | CASE 2 | CASE 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ELISA | IFA IgM/IgG c | RT-qPCR | ELISA IgM a/IgG b | IFA IgM/IgG c | RT-qPCR | ELISA IgM a/IgG b | IFA IgM/IgG c | RT-qPCR | |
| TBEV | NegNeg | NT | Neg | Neg/Neg | NT | Neg | Neg/Neg | NT | Neg |
| WNV | Neg/Neg | NT | Neg | Neg/Neg | NT | Neg | Neg/Neg | NT | Neg |
| USUV | NT/Neg | NT | Neg | NT/Neg | NT | Neg | NT/Neg | NT | Neg |
| SFSV | NT | Neg/Neg | NT | NT | Neg/Neg | NT | NT | Neg/Neg | NT |
| SFNV | NT | Neg/Neg | NT | NT | Neg/Neg | NT | NT | Neg/Neg | NT |
| SFCV | NT | Neg/Neg | NT | NT | Neg/Neg | NT | NT | Neg/Neg | NT |
| TOSV | NT | 1000/3200 | Neg | NT | 3200/3200 | Neg | NT | 1000/10,000 | Neg |
| TAHV | NT | NT | Neg | NT | NT | Neg | NT | NT | Neg |
| BHAV | NT | NT | Neg | NT | NT | Neg | NT | NT | Neg |
TBEV = tick-borne encephalitis virus; WNV = West Nile virus; USUV = Usutu virus; SFSV = sandfly fever Sicilian virus; SFNV = sandfly fever Naples virus; SFCV = sandfly fever Cyprus virus; TOSV = Toscana virus; TAHV = Tahyna virus; BHAV = Bhanja virus; NT = not tested; a ratio < 0.8 negative, 0.8−1.1 borderline, ≥ 1.1 positive; b RU/mL < 16 negative, 16−22 borderline, ≥ 22 positive; c titer < 100 negative.
Figure 1Toscana virus IgG antibodies detected using indirect immunofluorescence assay in a patient (case 3) with neuroinvasive infection.
Anti-Viral Cytokine Levels in Patients with Toscana Virus Neuroinvasive Infection.
| Cytokine (pg/mL) | Case 1 | Case 2 | Case 3 | Detection Limits (Minimum Detectable Concentrations + 2xSD, pg/mL) | |||
|---|---|---|---|---|---|---|---|
| Serum | CSF | Serum | CSF | Serum | CSF | ||
| IL-5 | Neg | Neg | 5.35 | Neg | Neg | 3.20 | 1.2 + 1.3 |
| IL-13 | Neg | Neg | 18.68 | Neg | 71.25 | 40.05 | 1.4 + 0.7 |
| IL-2 | 5.92 | Neg | Neg | Neg | Neg | 35.01 | 1.4 + 0.4 |
| IL-6 | Neg | 162.32 | 8.35 | 517.32 | 9.29 | 2683.90 | 1.0 + 0.8 |
| IL-9 | 5.51 | 5.01 | 4.80 | 2.13 | Neg | 7.62 | 1.7 + 1.4 |
| IL-10 | Neg | 199.99 | Neg | 28.08 | Neg | 858.91 | 0.7 + 0.4 |
| IFN-γ | Neg | 110.12 | 28.23 | 206.92 | Neg | 1568.07 | 1.1 + 0.7 |
| TNF-α | 13.75 | Neg | Neg | Neg | Neg | Neg | 0.7 + 0.5 |
| IL-17A | Neg | Neg | 32.94 | Neg | Neg | Neg | 1.9 + 0.6 |
| IL-17F | 15.21 | Neg | Neg | Neg | Neg | Neg | 0.8 + 0.7 |
| IL-4 | 18.43 | Neg | 5.97 | Neg | Neg | Neg | 1.0 + 0.8 |
| IL-21 | 78.13 | Neg | 10.98 | Neg | Neg | Neg | 6.0 + 3.0 |
| IL-22 | Neg | Neg | Neg | 28.49 | Neg | 45.24 | 1.5 + 0.5 |